• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content

    • Explore

      • Providers

        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions

        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges

        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors

        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap

        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
×

Test video

 
Loading...
ValiRx

ValiRx PLC

0.5p 0p 0%
Overview Research Videos News Events Transactions Financials
  • Today1 dy
  • 1 month1 mo
  • 3 months3 mo
  • 1 year1 yr
  • 5 years5 yr
working
working
working
working
working
  • Open 0.50p
  • Range Today 0.45/0.55p
  • 52 Week 0.38/4.49p
  • Daily Volume 754.1k
  • # Shares 374.3m
  • Daily Liquidity 0.20%
  • Enterprise Value £1.63m
  • Market Cap £1.87m
  • Sales Year
    2021
    2022
    2023
  • Sales
    0
    0
    0.010
  • Sales Growth
    n/a
    n/a
    n/a
  • Op. Profit
    -1.70
    -2.59
    -2.30
  • EBIT Growth
    -3.2
    -52.6
    11.4
  • Cash
    0.59
    1.14
    0.17
  • Net Debt
    -0.53
    -1.10
    -0.15
  • PE Ration
    n/a
    n/a
    n/a
  • Div Yield
    0-0
    0-0
    0-0
  • Today
  • 1 mo
  • 3 mos
  • 1 yr
  • 5 yr
working
working
working
working
working
  • Open 0.50p
  • Range Today 0.45/0.55p
  • 52 Week 0.38/4.49p
  • Daily Volume 754.1k
  • # Shares 374.3m
  • Daily Liquidity 0.20%
  • Enterprise Value £1.63m
  • Market Cap £1.87m
  • Sales Year
    2021
    2022
    2023
  • Sales
    0
    0
    0.010
  • Sales Growth
    n/a
    n/a
    n/a
  • Op. Profit
    -1.70
    -2.59
    -2.30
  • EBIT Growth
    -3.2
    -52.6
    11.4
  • Cash
    0.59
    1.14
    0.17
  • Net Debt
    -0.53
    -1.10
    -0.15
  • PE Ration
    n/a
    n/a
    n/a
  • Div Yield
    0-0
    0-0
    0-0

All info is indicative. Check data before any investment decision. We cannot guarantee accuracy or completeness, and accept no responsibility for its use.

Latest Research

loading

Latest Videos

loading

Latest Company Announcements

loading

Upcoming Events

loading

Latest Transactions

loading

Key Financials

loading

Key Valn Metrics / Ratios

loading

Related Companies

Loading...
Top Section Upper Central Html
ValiRx PLC is a life science company with a focus on clinical-stage drug development. The company trades under the ticker Lon:VAL
To access the html field for mobile you need to change the size of your browser window
Top left section Html - Shows for small and medium
Top left section Html - Show for large
Edit Image
Edit Image
Top right section Html - Show for large
Top right section Html - Shows for small and medium

Frequently asked questions

Strapline

Strapline
  • Question 1
    Answer 1
  • Question 2
    Answer 2
  • Question 3
    Answer 3
  • Question 4
    Answer 4
  • Question 5
    Answer 5
  • Question 6
    Answer 6
  • Question 7
    Answer 7
  • Question 8
    Answer 8
  • What is the latest ValiRx PLC share price?
    ValiRx PLC shares are currently trading at 0.5p. However there is at least a 15 minute delay on this figure.
  • What share price range is ValiRx PLC trading between today?
    The range ValiRx PLC has been trading between today is a low of 0.45p and a high of 0.55p per share.
  • How many ValiRx PLC shares are there in circulation?
    ValiRx PLC has 374.3m shares in circulation.
  • What is the average volume of ValiRx PLC shares that are traded each day?
    The average daily volume of ValiRx PLC shares traded, based on a rolling last 30 days, is 754.1k shares.
  • What is the share turnover, or daily liquidity, of ValiRx PLC shares?
    The share turnover, otherwise know as daily liquidity, of ValiRx PLC is 0.20%.
  • What is the market cap of ValiRx PLC?
    The ValiRx PLC market cap is £1.87m.
  • How many ValiRx PLC research reports are on average published each year on Research Tree?
    On average there are 12 research reports published on ValiRx PLC each year.
  • How many research reports are there in total on ValiRx PLC across Research Tree?
    There are 111 research reports on ValiRx PLC available through Research Tree, across both our institutional and non-institutional environments.
  • How many Brokers and other Research Houses are there on Research Tree who cover ValiRx PLC?
    The number of providers on Research Tree producing research on ValiRx PLC is 10, across both our institutional and non-institutional environments.
  • What ticker or security code does ValiRx PLC trade under?
    ValiRx PLC trades under the ticker VAL LN.
  • What exchange is ValiRx PLC primarily listed on?
    The primary exchange that ValiRx PLC is listed on is London Stock Exchange (domestic).
  • What other securities does ValiRx PLC trade under?
    ValiRx PLC trades under the following securities:
    • EAJF:FRA

Filters loading

Hide
Authors (All)
Ratings (All)
Provider (All)
Length (All)
Types (All)

Clear Filter

Feed 0 loading

Sorry an error has occurred click to retry

Most Viewed Research

loading

Most Viewed Media

loading
Key Announcements

Most Viewed RNS

loading
  • Upcoming Events
  • Previous Events

All Upcoming Events

Sorry an error has occurred
Loading...

All Past Events

Sorry an error has occurred
Loading...
  • Open Transactions
  • Completed Transactions

All Open Transactions

Sorry an error has occurred
Loading...

All Completed Transactions

Sorry an error has occurred
Loading...
working
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In